196 related articles for article (PubMed ID: 19760068)
1. OX40 (CD134) and OX40L.
Gough MJ; Weinberg AD
Adv Exp Med Biol; 2009; 647():94-107. PubMed ID: 19760068
[TBL] [Abstract][Full Text] [Related]
2. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
Redmond WL; Weinberg AD
Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
[TBL] [Abstract][Full Text] [Related]
3. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
4. OX40/OX40L axis: not a friend in autoimmunity.
Ueno H; Blanco P
Oncotarget; 2015 Sep; 6(26):21779-80. PubMed ID: 26314852
[No Abstract] [Full Text] [Related]
5. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
6. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
7. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
10. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
11. The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases.
Fu N; Xie F; Sun Z; Wang Q
Front Immunol; 2021; 12():670637. PubMed ID: 34234777
[TBL] [Abstract][Full Text] [Related]
12. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
[TBL] [Abstract][Full Text] [Related]
13. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; Mercié P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
[TBL] [Abstract][Full Text] [Related]
14. Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.
Tripathi T; Yin W; Xue Y; Zurawski S; Fujita H; Hanabuchi S; Liu YJ; Oh S; Joo H
Immunohorizons; 2019 Mar; 3(3):110-120. PubMed ID: 31240276
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
16. OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
Yan J; Su H; Xu L; Wang C
PLoS One; 2013; 8(4):e60854. PubMed ID: 23593329
[TBL] [Abstract][Full Text] [Related]
17. Control of immunity by the TNFR-related molecule OX40 (CD134).
Croft M
Annu Rev Immunol; 2010; 28():57-78. PubMed ID: 20307208
[TBL] [Abstract][Full Text] [Related]
18. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
[TBL] [Abstract][Full Text] [Related]
19. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
20. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
